Table 2 Rates of continued GP substance use treatment, respectively by the GP alone or mixed with non-GP treatment, and by the GP alone, according to patient characteristics
Continued substance use treatment by GP (alone or mixed with non-GP) | Continued substance use treatment by GP alone | |||||||
|---|---|---|---|---|---|---|---|---|
Yes (n = 155) | No (n = 324)a | Yes (n = 82) | No (n = 397)b | |||||
n/N | % (95% CI) | n/N | % (95% CI) | n/N | % (95% CI) | n/N | % (95% CI) | |
Men (versus women) | 96/154 | 62.3 (54.2–70.0) | 219/320 | 68.4 (63.0–73.5) | 55/82 | 67.0 (55.8–77.1) | 260/392 | 66.3 (61.4–71.0) |
Age in years | ||||||||
<25 | 7/155 | 4.5 (1.8–9.1) | 17/324 | 5.2 (3.1–8.3) | 1/82 | 1.2 (0.3–6.6) | 23/397 | 5.8 (3.7–8.6) |
25–34 | 22/155 | 14.2 (9.1–20.7) | 60/324 | 18.5 (14.4–23.2) | 4/82 | 4.9 (1.3–12.0) | 78/397 | 19.6 (15.9–23.9) |
35–44 | 34/155 | 21.9 (15.7–29.3) | 62/324 | 19.1 (15.0–23.8) | 20/82 | 24.4 (15.6–35.1) | 76/397 | 19.6 (15.9–23.9) |
45–54 | 61/155 | 39.4 (31.6–47.5) | 105/324 | 32.4 (27.3–37.8) | 39/82 | 47.6 (36.4–58.9) | 127/397 | 32.0 (27.4–36.8) |
55–64 | 31/155 | 20.0 (14.0–27.2) | 80/324 | 24.7 (20.1–29.8) | 18/82 | 22.0 (13.6–32.5) | 93/397 | 23.4 (19.3–27.9) |
Type of substance use | ||||||||
Alcohol alone | 64/155 | 41.3 (33.5–49.5) | 162/324 | 50.0 (44.4–55.6) | 33/82 | 40.2 (9.6–51.7) | 193/397 | 48.6 (43.6–53.7) |
Prescription drugs | 36/155 | 23.2 (16.8–30.7) | 61/324 | 18.5 (14.4–23.2) | 25/82 | 30.5 (20.8–41.6) | 72/397 | 17.9 (14.2–22.0) |
Illicit drugs, excl. heroin and methadone | 18/155 | 11.6 (7.0–17.7) | 62/324 | 19.1 (15.0–23.8) | 8/82 | 9.8 (4.3–18.3) | 72/397 | 18.1 (14.5–22.3) |
Heroin or methadone | 37/155 | 23.9 (17.4–31.4) | 39/324 | 12.0 (8.7–16.1) | 16/82 | 19.5 (11.6–29.7) | 60/397 | 15.1 (11.7–19.0) |
Substance use characteristics | ||||||||
Abstinence in last 4 weeks | 76/155 | 49.0 (40.9–57.2) | 150/324 | 46.3 (40.8–51.9) | 44/82 | 53.7 (42.3–64.7) | 182/397 | 45.8 (40.9–50.9) |
Single substance use | 94/155 | 60.6 (52.5–68.4) | 211/324 | 65.1 (59.7–70.3) | 58/82 | 70.7 (59.6–80.3) | 247/397 | 62.2 (57.2–67.0) |
Problematic use ≥10 years | 70/155 | 57.9 (48.5–66.8) | 143/324 | 56.7 (50.4–62.9) | 36/82 | 56.3 (43.3–68.6) | 177/309 | 57.3 (51.6–62.9) |
Substance use related problems | ||||||||
Physical problems | 71/155 | 45.8 (37.8–54.0) | 162/324 | 50.0 (44.4–55.6) | 37/82 | 45.1 (34.1–56.5) | 196/397 | 49.4 (44.3–54.4) |
Mental problems | 129/155 | 83.2 (76.4–88.7) | 249/324 | 76.9 (71.9–81.3) | 68/82 | 82.9 (73.0–90.3) | 310/397 | 78.1 (73.7–82.1) |
Problems at work | 26/155 | 16.8 (11.3–23.6) | 65/324 | 20.1 (15.8–24.8) | 8/82 | 9.8 (4.3–18.3) | 83/397 | 20.9 (17.0–25.2) |
Social problems | 118/155 | 76.1 (68.6–82.6) | 233/324 | 71.9 (66.7–76.7) | 62/82 | 75.6 (64.9–84.4) | 289/397 | 72.9 (68.1–77.1) |
Occupational status: at work | 47/155 | 31.5 (24.2–39.7) | 133/309 | 43.0 (37.4–48.8) | 27/82 | 34.6 (24.2–46.2) | 153/380 | 40.3 (35.3–45.4) |
Treatment history | ||||||||
First treatment episode | 32/155 | 21.6 (15.3–29.1) | 73/289 | 25.3 (20.4–30.7) | 22/82 | 27.2 (18.3–39.1) | 83/358 | 23.2 (18.9–27.9) |
Ongoing treatment episode (versus new) | 39/155 | 74.8 (67.2–81.5) | 188/309 | 60.8 (55.2–66.3) | 20/82 | 75.6 (64.9–84.4) | 242/382 | 63.4 (58.3–68.2) |
Wallonia-Brussels (versus Flanders) | 90/155 | 58.1 (49.9–65.9) | 121/324 | 37.3 (32.1–42.9) | 50/82 | 61.0 (49.6–71.6) | 161/397 | 40.6 (35.7–45.6) |